Northwest & Ethical Investments L.P. lifted its holdings in shares of Genpact Limited (NYSE:G – Free Report) by 10.7% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 290,166 shares of the business services provider’s stock after acquiring an additional 28,068 shares during the period. Northwest & Ethical Investments L.P. owned 0.16% of Genpact worth $11,377,000 at the end of the most recent reporting period.
A number of other institutional investors have also modified their holdings of G. Dimensional Fund Advisors LP grew its stake in shares of Genpact by 34.2% in the 2nd quarter. Dimensional Fund Advisors LP now owns 3,326,054 shares of the business services provider’s stock valued at $107,065,000 after purchasing an additional 847,249 shares during the last quarter. Pzena Investment Management LLC increased its stake in Genpact by 130.3% in the 2nd quarter. Pzena Investment Management LLC now owns 1,163,870 shares of the business services provider’s stock valued at $37,465,000 after buying an additional 658,560 shares during the period. Los Angeles Capital Management LLC purchased a new position in Genpact during the 3rd quarter worth $19,779,000. Tandem Investment Advisors Inc. acquired a new stake in shares of Genpact in the 3rd quarter worth $17,025,000. Finally, Vulcan Value Partners LLC boosted its holdings in shares of Genpact by 22.2% in the second quarter. Vulcan Value Partners LLC now owns 1,567,428 shares of the business services provider’s stock valued at $50,456,000 after acquiring an additional 284,842 shares in the last quarter. 96.03% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
Several research analysts recently issued reports on G shares. TD Cowen increased their price target on shares of Genpact from $40.00 to $45.00 and gave the stock a “hold” rating in a report on Friday, November 8th. BMO Capital Markets lifted their price target on Genpact from $38.00 to $42.00 and gave the company a “market perform” rating in a research note on Monday, August 12th. Needham & Company LLC upped their price objective on Genpact from $42.00 to $55.00 and gave the stock a “buy” rating in a report on Monday, November 11th. Jefferies Financial Group raised their target price on Genpact from $35.00 to $40.00 and gave the company a “hold” rating in a report on Monday, September 9th. Finally, JPMorgan Chase & Co. upped their price target on shares of Genpact from $35.00 to $43.00 and gave the stock a “neutral” rating in a research note on Friday, September 6th. Eight investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $42.33.
Genpact Trading Down 0.7 %
Shares of G stock opened at $46.49 on Friday. Genpact Limited has a fifty-two week low of $30.23 and a fifty-two week high of $47.98. The company has a quick ratio of 1.85, a current ratio of 1.85 and a debt-to-equity ratio of 0.50. The business has a fifty day simple moving average of $41.02 and a 200-day simple moving average of $36.89. The stock has a market cap of $8.20 billion, a P/E ratio of 12.77, a P/E/G ratio of 1.60 and a beta of 1.13.
Genpact Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Monday, December 23rd. Shareholders of record on Monday, December 9th will be given a dividend of $0.1525 per share. This represents a $0.61 dividend on an annualized basis and a yield of 1.31%. The ex-dividend date of this dividend is Monday, December 9th. Genpact’s payout ratio is currently 16.76%.
Insider Buying and Selling at Genpact
In other news, CEO Balkrishan Kalra sold 9,000 shares of the company’s stock in a transaction on Monday, November 25th. The stock was sold at an average price of $46.40, for a total value of $417,600.00. Following the sale, the chief executive officer now directly owns 267,404 shares in the company, valued at $12,407,545.60. This represents a 3.26 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 2.80% of the company’s stock.
About Genpact
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
See Also
- Five stocks we like better than Genpact
- CD Calculator: Certificate of Deposit Calculator
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- How to Invest in Tech StocksĀ and Top Tech Stocks to Consider
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- 3 Stocks to Consider Buying in October
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Want to see what other hedge funds are holding G? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genpact Limited (NYSE:G – Free Report).
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.